ADMA Biologics Inc (NASDAQ:ADMA)

8.46
Delayed Data
As of May 22
 +0.02 / +0.24%
Today’s Change
7.16
Today|||52-Week Range
14.00
-24.26%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close8.44
Today’s open8.50
Day’s range8.35 - 8.50
Volume3,500
Average volume (3 months)22,450
Market cap$90.6M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+23.95%
Earnings growth (this year)-2.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+92.84%
P/E ratioNM
Price/Sales17.55
Price/Book13.08

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...+0.01+0.49%
TENXTenax Therapeutics I...+0.03+0.86%
ORPNBio Blast Pharma Ltd-0.03-0.54%
CFRXContraFect Corp+0.01+0.24%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$5.9M
Annual profit (last year)-$16.8M
Net profit margin-284.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial Officer &
Vice President
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers